Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif
Tuesday, June 24, 2014
First revenues from VolitionRx Nucleosomics technology.

New Webinar on Improving Process Development Timelines with Mini Bioreactors
Saturday, June 21, 2014
Details fermentation and bioprocessing data generated by ambr250.

Lonza Innovation Showcase Features Novel Culture System at ISSCR
Saturday, June 21, 2014
Company has introduced L7™ hiPSC reprogramming and hPSC culture system at ISSCR.

Updates to Eppendorf Website Combine Online Purchasing with a Wealth of Information
Friday, June 20, 2014
New, updated version of Eppendorf’s UK website.

lnSphero Launches Cytotoxicity Assay Kit for 3D Cell Culture
Wednesday, June 18, 2014
The Assay Kit incorporates Promega technology to measure cell viability in 3D microtissues, offering complete solution for toxicity and efficacy testing.

lnSphero Launches 3D InSight™ Pancreatic Microislets for Diabetes, Toxicity Research
Wednesday, June 18, 2014
Recently published 3D human and rat "pseudo­ islets" display long-lived, robust metabolic activity, offer convenient solution for islet transplantation, anti-diabetic drug development, and assessment of acute and chronic toxicity of the endocrine pancreas.

Leica Microsystems Releases Application Suite Advanced Fluorescence 4.0
Friday, June 13, 2014
Image analysis, environmental control and experiment handling via mobile devices for life science research.

Promega Launches CellTiter-Glo® 3D Cell Viability Assay
Thursday, June 12, 2014
Designed specifically for 3D microtissue culture.

New MCO-170AIC CO2 incubator from Panasonic demonstrates exceptional control and optimises cell culture productivity
Monday, June 09, 2014
New MCO-170AIC CO2 incubators from Panasonic deliver outstanding quality in performance, maximise cell culture efficiency and provide optimum results and reproducibility. Designed specifically for the safe, consistent cultivation of successful cell lines, this latest innovation offers the very highest levels of precision, security and ease of use.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 238
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv